MedTrace Logo

Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)

NCT04169529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2024-10-26

Study results available
· View outcomes & findings →

Summary

The purpose of the LINQ™ for COPD study is to characterize Reveal LINQ™ derived data from patients with COPD by assessing the relationship between changes in LINQ™ derived data with COPD exacerbation events.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DEVICE

Reveal LINQ

Insertion of Reveal LINQ device to characterize collected data from patients with COPD.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Christine Wendt, MD · U.S. Department of Veterans Affairs Minneapolis Healthcare System

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-25
Primary Completion
2023-06-27
Completion
2023-06-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169529 on ClinicalTrials.gov